N-(8.alpha.-ergolinyl)-amides

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

546 18, 546 68, A61K 3148, A61K 3144, C07D45712, C07D45702

Patent

active

055479588

ABSTRACT:
8.alpha.-acylamino ergolines are useful dopamine agonists.

REFERENCES:
patent: 2864822 (1958-12-01), Fornefeld et al.
patent: 4764517 (1988-08-01), Gull
patent: 4766128 (1988-08-01), Sauer et al.
patent: 4772610 (1988-09-01), Biere et al.
patent: 4791115 (1988-12-01), Habfliger
patent: 4826852 (1989-05-01), Haffer et al.
patent: 4950672 (1992-08-01), Habfliger
Nordmann et al, Helvetica Chem. Acta, vol. 69, pp. 246 to 250 (1986).
Stutz et al, Eur. J. Med Chem.-Chim.Ther, vol. 17, pp. 537-541 (1982).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

N-(8.alpha.-ergolinyl)-amides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with N-(8.alpha.-ergolinyl)-amides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-(8.alpha.-ergolinyl)-amides will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2330928

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.